Quadrant Capital Group LLC Lowers Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Quadrant Capital Group LLC reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 7.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 2,114 shares of the company’s stock after selling 161 shares during the period. Quadrant Capital Group LLC’s holdings in HCA Healthcare were worth $572,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Kinetic Partners Management LP purchased a new position in HCA Healthcare in the 3rd quarter worth approximately $50,524,000. EP Wealth Advisors LLC raised its stake in HCA Healthcare by 501.8% in the third quarter. EP Wealth Advisors LLC now owns 208,965 shares of the company’s stock worth $51,401,000 after buying an additional 174,240 shares in the last quarter. Retirement Systems of Alabama boosted its position in HCA Healthcare by 350.0% during the 4th quarter. Retirement Systems of Alabama now owns 204,812 shares of the company’s stock valued at $55,439,000 after acquiring an additional 159,303 shares in the last quarter. Canada Pension Plan Investment Board lifted its stake in shares of HCA Healthcare by 51.6% in the 3rd quarter. Canada Pension Plan Investment Board now owns 355,730 shares of the company’s stock valued at $87,502,000 after purchasing an additional 121,100 shares during the period. Finally, Mitsubishi UFJ Trust & Banking Corp grew its position in shares of HCA Healthcare by 83.4% in the 3rd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 254,408 shares of the company’s stock worth $62,579,000 after buying an additional 115,720 shares during the period. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have commented on HCA. Royal Bank of Canada boosted their target price on HCA Healthcare from $322.00 to $329.00 and gave the stock an “outperform” rating in a report on Monday, April 29th. Raymond James increased their target price on HCA Healthcare from $300.00 to $330.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. Cantor Fitzgerald reiterated an “overweight” rating and issued a $335.00 price objective on shares of HCA Healthcare in a report on Wednesday, April 10th. Wells Fargo & Company increased their price objective on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research report on Thursday, March 28th. Finally, StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Four equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $317.00.

Read Our Latest Stock Analysis on HCA Healthcare

HCA Healthcare Stock Up 0.0 %

HCA stock opened at $322.86 on Friday. The firm has a 50-day moving average of $319.96 and a two-hundred day moving average of $303.02. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26. The company has a market cap of $84.56 billion, a price-to-earnings ratio of 16.09, a PEG ratio of 1.50 and a beta of 1.66. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $335.83.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, beating the consensus estimate of $5.01 by $0.35. The firm had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $16.81 billion. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The firm’s revenue for the quarter was up 11.2% on a year-over-year basis. During the same quarter last year, the firm earned $4.93 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 20.79 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Friday, June 14th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.82%. HCA Healthcare’s payout ratio is 13.16%.

HCA Healthcare declared that its board has authorized a share buyback program on Tuesday, January 30th that authorizes the company to repurchase $6.00 billion in shares. This repurchase authorization authorizes the company to repurchase up to 7.4% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s leadership believes its stock is undervalued.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 1,600 shares of the stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the sale, the executive vice president now owns 34,124 shares in the company, valued at $10,544,316. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, SVP Chad J. Wasserman sold 876 shares of the business’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the sale, the senior vice president now owns 1,576 shares of the company’s stock, valued at approximately $520,474. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 1,600 shares of the company’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $309.00, for a total value of $494,400.00. Following the completion of the sale, the executive vice president now directly owns 34,124 shares in the company, valued at approximately $10,544,316. The disclosure for this sale can be found here. Insiders have sold a total of 13,617 shares of company stock worth $4,321,986 over the last ninety days. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.